ARCHIVES

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

This article is from The Cancer Letter archive.

Vol. 33 No. 45 | December 7, 2007

Download PDF Visit The Full Archive

Related Articles

House Passes Cancer Act Renewal With Provision Permitting NCI To Reinstate Training Program

May 10, 1974

Avastin Approved To Treat Progressive Glioblastoma

May 29, 2009

Mothers’ Smoking, Depression Influences Teen Smoking

May 28, 2010

South Carolina Politicos Join Hollings Oncology Center Section

October 30, 1992

In Brief: Hammer Hears A Claim for The $1 Million Wynder’s Theory On Japan’s Colon Cancer Rates: Hamburgers

March 19, 1982

Clinical Trials Approved By NCI’s CTEP Listed

February 25, 2005